SRPT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SRPT Shares Outstanding History and SRPT YTD Return |
SRPT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SRPT Shares Outstanding History and SRPT YTD Return |
SRPT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+52.70% CAGR Mouse over chart for data details
|
SRPT Stock Price Chart |
About Sarepta Therapeutics Inc |
Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping. We show 47 historical shares outstanding datapoints in our SRPT shares outstanding history coverage, used to compute SRPT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SRPT market cap history over the course of time is important for investors interested in comparing SRPT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SRPT versus a peer is one thing; comparing SRPT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SRPT can fluctuate over the course of history. With this page we aim to empower investors researching SRPT by allowing them to research the SRPT market cap history. |
SRPT Current Stock Quote |
Free SRPT Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
SRPT Share Performance |
Market Cap Peers |
Sarepta Therapeutics (SRPT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SRRA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.